A trial of 2-hydroxyoleic acid (2-OHOA) for people with a brain tumour or solid tumour that has spread (2-OHOA study)
Cancer type:
Status:
Phase:
This trial looked 2-hydroxyoleic acid (2-OHOA) for people who had a certain type of brain tumour or a solid tumour.
The type of brain tumour is called a glioma.
A is any type of cancer apart from
or
.
More about this trial
- find the best dose of 2-OHOA
- learn about the side effects
- see what happened to 2-OHOA in the body
- find out how well 2-OHOA worked for different types of cancer
Summary of results
- 1 person it had shrunk considerably (a partial response) and this lasted for more than 2½ years
- 3 people it had stayed the same (stable disease) for at least 6 weeks
- 4 people it had stayed the same for 6 months or more
- 1 person their solid tumour had stayed the same for about 10 months (45 weeks)
- 1 person their solid tumour had stayed the same for 3 months
- 1 person their solid tumour had stayed the same for 5 months
- 2 people their solid tumour had stayed the same for 2 months
- diarrhoea
- feeling or being sick

Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Chief Investigator
Professor Johann de Bono
Supported by
Experimental Cancer Medicine Centre (ECMC)
Lipopharma Therapeutics SL
If you have questions about the trial please contact our cancer information nurses
Freephone 0808 800 4040